Overview
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency (sometimes called partial IRF8 deficiency or MSMD due to partial IRF8 deficiency) is a very rare inherited immune disorder. It affects the body's ability to fight off certain types of bacteria called mycobacteria. These include the bacteria that cause tuberculosis (TB) as well as other less common mycobacteria found in the environment, such as BCG (the weakened tuberculosis strain used in vaccines) and nontuberculous mycobacteria. People with this condition have a partially working version of the IRF8 protein, which plays an important role in how immune cells — especially dendritic cells and macrophages — respond to infections. Because the immune defense against mycobacteria is weakened but not completely absent, people with partial IRF8 deficiency typically develop infections that are more severe or harder to clear than in healthy individuals, but the condition is generally less severe than complete IRF8 deficiency. Symptoms usually include recurrent or persistent mycobacterial infections, which can affect the lungs, lymph nodes, bones, or skin. Some patients may also be more susceptible to certain other intracellular infections. Treatment focuses on aggressively treating mycobacterial infections with appropriate antibiotics, often for prolonged courses. Preventive strategies include avoiding BCG vaccination and minimizing exposure to environmental mycobacteria. In some cases, immune-boosting therapies such as interferon-gamma (IFN-γ) may be considered. With proper management and awareness, many patients can lead relatively normal lives, though lifelong vigilance against infections is necessary.
Also known as:
Key symptoms:
Recurrent or severe mycobacterial infectionsSwollen lymph nodes that do not resolve easilyPersistent lung infectionsBone infections (osteomyelitis)Skin infections or abscessesSevere reaction to BCG vaccineProlonged feversWeight loss or failure to thrive in childrenFatigue and general weaknessNight sweats
Clinical phenotype terms (3)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency.
Community
No community posts yet. Be the first to share your experience with Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency.
Start the conversation →Latest news about Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency
No recent news articles for Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is my (or my child's) immune deficiency, and what infections am I most at risk for?,Should I avoid any vaccines, and which ones are safe?,Do I need to take preventive antibiotics, and for how long?,Would interferon-gamma therapy be helpful in my case?,What signs of infection should prompt me to seek emergency care?,Should my family members be tested for this genetic condition?,Are there any activities or environments I should avoid to reduce infection risk?
Common questions about Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency
What is Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency?
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency (sometimes called partial IRF8 deficiency or MSMD due to partial IRF8 deficiency) is a very rare inherited immune disorder. It affects the body's ability to fight off certain types of bacteria called mycobacteria. These include the bacteria that cause tuberculosis (TB) as well as other less common mycobacteria found in the environment, such as BCG (the weakened tuberculosis strain used in vaccines) and nontuberculous mycobacteria. People with this condition have a partially working version of the IRF8 protein, wh
How is Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency inherited?
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.